BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect

Clinical trial NCT03212586 · COMPLETED

Trial details

NCT number: NCT03212586
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Trials, Phase I as Topic

Start date: 2017-07-18
Primary completion: 2018-05-03
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.